These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2585 related articles for article (PubMed ID: 732331)

  • 1. BCG immunotherapy: effects of dose and route of administration on survival of mice bearing established tumors.
    Codish SD; Monaco AP
    J Surg Oncol; 1978; 10(5):447-55. PubMed ID: 732331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.
    Spence RJ; Simon RM; Baker AR
    J Natl Cancer Inst; 1978 Feb; 60(2):451-9. PubMed ID: 621758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of intratumoral injection of bcg and other substances in rats and mice.
    Chassoux D; Salomon JC
    Int J Cancer; 1975 Oct; 16(4):515-25. PubMed ID: 1176205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R; Nacy CA; Eisenstein TK
    J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapeutic trials of murine and guinea-pig solid tumors by oral administration of BCG.
    Tokunaga T; Taguchi S; Chino F; Murohashi T
    Jpn J Med Sci Biol; 1979 Feb; 32(1):1-18. PubMed ID: 470220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term protection in bladder cancer following intralesional immunotherapy.
    Reichert DF; Lamm DL
    J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
    Lynch NR; Salomon JC
    J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local tumor regression after intralesional injection of croton oil.
    Yarkoni E; Rapp HJ
    J Natl Cancer Inst; 1979 Aug; 63(2):503-5. PubMed ID: 287839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG therapy of pleural and peritoneal growth of transplanted rat tumours.
    Pimm MV; Baldwin RW
    Int J Cancer; 1975 Feb; 15(2):260-9. PubMed ID: 165155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
    Lee YT
    Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor effect of Bacillus Calmette-Guérin in combination with fibrinogen on urinary bladder tumor.
    Mizutani Y; Nio Y; Fukumoto M; Yoshida O
    J Urol; 1994 May; 151(5):1420-6. PubMed ID: 8158799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA; Kleinerman J; Saidel GM
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent adjuvant effects of Bacillus Calmette-Guérin on tumor immunity in Lewis rats.
    Davies M; Sabbadini E
    Cancer Res; 1979 Mar; 39(3):959-65. PubMed ID: 311684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.
    Sparks FC; Breeding JH
    Cancer Res; 1974 Dec; 34(12):3262-9. PubMed ID: 4471640
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria.
    Yarkoni E; Rapp HJ
    Cancer Res; 1979 Feb; 39(2 Pt 1):535-7. PubMed ID: 761228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dose, route, and schedule of BCG on antibody titer and survival of murine skin grafts across a weak histocompatibility barrier.
    Wile AG; Sparks FC
    Cancer; 1977 Feb; 39(2):570-4. PubMed ID: 319893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prophylactic and therapeutic administration of BCG vaccine on growth of experimental sarcoma.
    Símová J; Bubeník J
    Folia Biol (Praha); 1975; 21(5):329-33. PubMed ID: 172377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allium sativum (garlic) treatment for murine transitional cell carcinoma.
    Riggs DR; DeHaven JI; Lamm DL
    Cancer; 1997 May; 79(10):1987-94. PubMed ID: 9149027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulomas in melanoma patients treated with BCG immunotherapy.
    Hatzitheofilou C; Obenchain DF; Porter DD; Morton DL
    Cancer; 1982 Jan; 49(1):55-60. PubMed ID: 7053820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 130.